The 18th Annual Symposium on Anti-Angiogenesis and Immune Therapies for Cancer 2016 covers topics such as:
- Stromal therapy and targets in the tumor microenvironment
- Rationale for and mechanisms of action of novel anti-angiogenic and immune-targeted strategies
- Controversies with the new therapeutics, mechanisms of resistance, unique adverse events, and ongoing clinical trials
- Combination regimens
sessions will include:
- Crosstalk in Tumor Immunology and Preclinical Modeling
- Basic Science: Update on Angiogenesis and Tumor Immunology
- Controversies with New Therapeutics Targeting Angiogenesis and Tumor Immunology
- Novel Approaches to Activate the Immune Response to Tumor Antigens
- Overview of Clinical Trials of AgentsTargeting Angiogenesis and Tumor Immunology: Clinical Trial Overview
- Biomarkers and Predictors of Response
The 18th Annual Symposium on Anti-Angiogenesis and Immune Therapies for Cancer 2016 brings together clinicians, scientists, and other healthcare professionals who work in the area of tumor immunology.
